Breast cancer histologic subtypes show excess familial clustering-Reference-Cited by-同舟云学术

Breast cancer histologic subtypes show excess familial clustering

Published:2019-05-23 Issue:18 Volume:125 Page:3131-3138
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Henry N. Lynn¹²^ORCID,Cannon‐Albright Lisa A.²³⁴^ORCID

Affiliation:

1. Division of Oncology, Department of Internal Medicine University of Utah School of Medicine Salt Lake City Utah

2. Huntsman Cancer Institute Salt Lake City Utah

3. Division of Epidemiology, Department of Internal Medicine University of Utah School of Medicine Salt Lake City Utah

4. George E. Wahlen Department of Veterans Affairs Medical Center Salt Lake City Utah

Funder

National Cancer Institute

Centers for Disease Control and Prevention

Huntsman Cancer Foundation

Huntsman Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32198

Reference24 articles.

1. World Health Organization classification of tumors

2. Genomic, transcriptomic, epigenetic, and immune profiling of mucinous breast cancer [published online February 21, 2019];Nguyen B;J Natl Cancer Inst

3. Mucinous breast carcinomas lack PIK3CA and AKT1 mutations

4. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer;Cancers;2024-07-24

2. Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-14

3. MEX3A Drives Triple-Negative Breast Cancer Migration, Invasion, and Metastasis by Interacting with NTRK1;J BIOL REG HOMEOS AG;2024

4. Novel immunotherapies for breast cancer: Focus on 2023 findings;International Immunopharmacology;2024-02

5. Tumor Microenvironment Modulation and Its Impact on Immunotherapy in Triple-Negative Breast Cancer;Interdisciplinary Cancer Research;2024